14th Tumour Models London Summit 2025
WuXi AppTec is pleased to participate in the Tumour Models London 2025 conference, taking place December 3–4, 2025, in London, United Kingdom. This meeting brings together experts from pharma, biotech, and academia to discuss the latest advances in in vivo, ex vivo, and complex in vitro models used to evaluate oncology therapies. With a strong emphasis on translational relevance, the event highlights emerging approaches that improve predictability, refine model selection, and enhance decision-making across preclinical oncology research.
At Tumour Models London 2025, the program covers topics such as model validation, tumour heterogeneity, immuno-oncology model systems, PK/PD considerations, and strategies for improving clinical translatability. It provides an important venue for researchers and drug developers to explore how next-generation tumour models can better support candidate screening, mechanism-of-action studies, resistance evaluation, and combination-therapy development.
At WuXi AppTec, our oncology research services are built to support the progression of therapeutic programs through comprehensive biological evaluation. From early discovery through IND-enabling studies, our global platform helps accelerate development with rigor, quality, and scientific insight.
We invite you to visit us at Booth 1 to learn more about how our tumour model capabilities and integrated discovery services can support your oncology programs. We look forward to connecting in London and discussing how we can help advance the next generation of cancer therapies.
To schedule a dedicated meeting with our team, please fill out the form on the right.
Resource Links
WuXi AppTec Biology Services
Resource Type: Brochure
